The STATinMED team is thrilled to once again participate in the upcoming European Society of Cardiology (ESC) Congress 2021. Our team co-authored 7 poster presentations on topics assessing patient outcomes among those diagnosed with atrial fibrillation and venous thromboembolism.
Poster Presentations
-
-
- Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants vs warfarin
- Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: An ARISTOPHANES analysis
- Effectiveness and safety of non-vitamin K antagonist oral anticoagulants among nonvalvular atrial fibrillation patients with prior bleeding events
- Effectiveness and safety of non-vitamin K antagonist oral anticoagulants vs warfarin among nonvalvular atrial fibrillation patients with prior bleeding events
- Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: A subgroup analysis of age
- Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients using five US databases: A subgroup analysis of chronic liver disease
- Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
-
